• 7 Feb 2023
  • 9:00 AM - 4:30 PM (PST)
  • Fairmont Hotel Vancouver



The Fairmont Hotel Vancouver
900 West Georgia Street, 
Vancouver, BC 

Book your guestroom at the Fairmont Hotel Vancouver, simply click on https://book.passkey.com/go/CAHRWesternDay.  

Featuring Wendy Hurlburt, BC Life Sciences
and Ali Ardakani, Novateur Ventures Inc.
Monday, February 6 | 6:00 PM – 8:00 PM PT
Saltspring Island Room

Pharma policy during periods of crisis is critical to addressing current issues and evolving the system to be prepared for the future. This encapsulates some of the important work of Life Sciences BC as it engages both with the federal and provincial issues of our time. Join Wendy Hurlburt, President and CEO of Life Sciences BC, and Ali Ardakani, Founder and Managing Director, Novateur Ventures Inc., and Chair of the Board at Life Sciences BC, for cocktails and a brief presentation on the evening of February 6th. Wendy and Ali will provide an overview of some of the recent successes of the Life Sciences community from a policy and crisis perspective and their vision for the future as they set the stage for the February 7th conference.

Tuesday, February 7 | 9:00 AM – 4:15 PM PT
Saturna Island Room

The past few years have stressed virtually every aspect of our Canadian healthcare system, exposing areas of strength and need without prejudice. Western Day 2023 is embarking on a bold agenda with a return to an in-person venue focused on the policy challenges and advancements revealed by the recent and ongoing healthcare crisis. A political perspective on Health Reform will provide the backdrop as we explore advancements in negotiations and pCPA, the evolving and advancing role of pharmacists in a solutions-driven environment, examine the progress towards a more consistent framing and incorporation of the emerging science of RWE, and providing a lens on policy development from the patient’s perspective.


Emcee: Gerry Jeffcott, 3Sixty Public Affairs

9:10 AM
Opening Panel: Political Perspective on Health & Pharmaceutical Policy

The panel will provide an assessment of the political scene in the West and explore what is driving political decision-making in the region currently. It will explore that in context of the ongoing health care crisis that all provinces are coping with and offer perspective on how those broader political winds and health reform imperatives are affecting pharmaceutical policy, and particularly what impact they might be having on improving patient access to important new treatments.

Lee Funke, Torque Communications
Jean-Marc Prévost, Counsel Public Affairs
Steve Vander Wal, Santis Health

Moderated by Don Wright, Global Public Affairs

10:00 AM
Steve Long Memorial Keynote Address: Using Mindset to Negotiate Effectively with Stakeholders 

Nick Doulias

Nick will reflect on his time as the Executive Director of the Saskatchewan drug benefit plan and offer insights about how innovators could conduct themselves during the national product review and approval process to support access to new innovative medicines.


11:10 AM
 Pharmacists in a Time of Crisis – How They Are Driving Access Solutions

Pharmacists have been filling gaps in provincial health care for years, from providing assessments and treatments to addressing minor ailments, to helping patients navigate reimbursement in an increasingly complex market access environment. Join representatives from Western Canadian pharmacists’ associations as they discuss how pharmacists have not only stepped up during this time of health care crisis, but also how they are driving health policy and innovation to ensure patients remain at the centre of care.

Heads of Pharmacy Association:

  • Alberta: Margaret Wing
  • BC: Geraldine Vance
  • Manitoba: Darren Murphy
  • Saskatchewan: Michael Fougère
Moderated by Shanta Zurock, Innomar Strategies


1:15 PM
Panel: What Does Healthcare Reform Mean at the Patient Level?

Patients collective involvement in their own health has accelerated through the pandemic and as reform evolves in cancer care, primary care, surgery, etc., patients and patient groups are taking a leadership role in care pathways, input into HTA and continuing to evolve as a critical voice in what health reform looks like. This panel of patient experts will talk about their experience and vision for the current state of patient engagement in health reform and where they see a further role being played in the months and years ahead.

Beth Kidd, Health Coalition of Alberta
Gail Attara, Gastrointestinal Society (GI Society)

Co-moderated by Ursula Mann, PatientVoicePartners and Laura Fitzgerald, GSK

2:15 PM
Panel: The Continuing Evolution of RWE in the Canadian Market Access Environment

This session will offer a Western Canadian overview of how RWE is evolving and explore how innovators can collaborate. It will also examine opportunities for innovators to obtain Canadian real-world data to support patient access to new treatments. Several researchers will explain their roles in producing RWE and how they are working with the industry. A discussant from the industry will react and offer views on how the work could support patient access.

Tyler Williamson, University of Calgary
Virginie Giroux, Merck
Winson Cheung, Oncology Outcomes

Moderated by Brent Korte, Korte Consulting


3:30 PM
ADM Panel

Join Stephen and the Western ADMs for a fireside chat-style ADM Panel Session to close out the day. We will examine their thoughts and insights on some of the major efforts they are currently focused on, their input on topics presented throughout the day, what they view as critical over the next few years, how negotiations are evolving and what changes are needed. We will also look at their role in this time of healthcare crisis and that of the formularies. As always, audience participation through questions will be most welcomed.

Raelynn Douglas, SK
Chad Mitchell, AB
Mitch Moneo, BC

Moderated by Stephen Filbey, WESTPar Consultancy Inc.

Emcee: Gerry Jeffcott, 3Sixty Public Affairs

For a copy of the agenda, click here.

The fee includes the Welcome Reception on Monday, February 6
and the full day of the Educational Program on Tuesday, February 7.

MEMBER: $695.00 + $34.75 (5% BC GST) = $729.75 
NON-MEMBER: $995.00 + $49.75 (5% BC GST) = $1,044.75
* PATIENT / STUDENT ATTENDEE: $150.00 + $7.50 (5% BC GST) = $157.50
* Registration code required. Please contact the CAHR office info@cahr-acrss.ca to obtain the code.

CAHR reserves the right to cancel or change speakers, content and date without prior notice. We assume no liability for these changes. Cancellation PolicyFor cancellations two (2) weeks or more in advance, delegates will receive a 75% refund. Cancellations made less than two (2) weeks in advance, no refunds are given.  Delegate substitutions will be accepted at no cost.

The Canadian Association for Healthcare Reimbursement

250 Consumers Road, Suite 301, Toronto, ON, M2J 4V6

 Phone 416.494.1440 X 258 |  F: 416.495.8723  | Email: info@cahr-acrss.ca

Copyright ©   2020 The Canadian Association for Healthcare Reimbursement

Powered by Wild Apricot Membership Software